GBA Holding GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
GBA Holding GmbH - overview
Established
1989
Location
Hamburg, -, Germany
Primary Industry
Biotechnology
About
Based in Germany, GBA Holding GmbH is a laboratory services provider specializing in life sciences, offering analytical, logistical, and consulting services across multiple sectors including pharmaceuticals and environmental analysis. GBA Holding GmbH is a laboratory services provider founded in 1989 and headquartered in Hamburg, Germany. The company has undergone strategic pivots to enhance its service offerings. In November 2024, GBA Holding GmbH, a portfolio company of Ardian and Quadriga Capital, acquired a majority stake in NIUTEC AG.
Financial terms of the transaction were not disclosed. GBA Group is an international life science service provider offering a comprehensive range of analytical, logistical, and specialized services across various sectors, including pharmaceuticals, medical devices, cosmetics, chemicals, food safety, drinking water, and environmental analysis. The company provides laboratory analytics, data management, specialized logistical services related to clinical trials, and consulting for private companies and public institutions in research, product development, market entry, and consumer protection. GBA Group serves a diverse client base in multiple geographical markets, including Germany, Belgium, France, the Netherlands, the United States, and several others, addressing the unique needs of industries focused on health, safety, and environmental sustainability while aiming to enhance product quality and regulatory compliance.
These transactions often occur in a B2B environment, where companies engage GBA Group for tailored analytical services or ongoing partnerships related to clinical studies and product compliance. Following the acquisition in February 2021, GBA Holding GmbH plans to leverage the investment for organic growth, focusing on expanding its business operations and improving its service offerings. The company is strategically looking to enhance its product lines and may target new geographical markets to bolster its presence. This acquisition provides the necessary capital to support these initiatives.
Current Investors
Ardian, Quadriga Capital
Primary Industry
Biotechnology
Sub Industries
Consulting Services, Biotechnology
Website
www.gba-group.com/
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
GBA Holding GmbH - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Revenue (USD) | 12,576,100.3 | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - |
| EBITDA (USD) | (2,408,379) | - | - | - | - |
| Operating Income (USD) | (7,268,432.6) | - | - | - | - |
| Operating Margin | (57.8%) | - | - | - | - |
| % EBITDA Margin | (19.2%) | - | - | - | - |
| NET Income (USD) | (9,308,138.2) | - | - | - | - |
| % Net Margin | (74.0%) | - | - | - | - |
GBA Holding GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Teena Biolabs Pvt Ltd | - | ||||||||
| Add-on | Completed | Niutec AG | - | ||||||||
| Add-on | Completed | Eureka Analytical Services Private Limited | - | ||||||||
| Add-on, Trade Sale | Completed | ICCR-Roßdorf GmbH | - | ||||||||
| Secondary Buyout | Completed | GBA Holding GmbH | - |
Displaying 1 - 5 of 12
GBA Holding GmbH - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.